MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Diaceutics wins Covid-19 testing data licensing contract

StockMarketWire.com

Healthcare diagnostic company Diaceutics said it had won a data licensing contract with a pharmaceutical company to provide COVID-19 testing data insights in the US.

This contract win 'highlights that the group is in a position to address the imminent opportunity presented by the COVID-19 treatment market using its DXRX data solution capabilities,' the company said.

The financial details of the contract weren't disclosed and the company said the contract value does not change management's expectations of performance for the current financial year.



Story provided by StockMarketWire.com